Generate Biomedicines Inc 's ROA from the second quarter of 2026 to the second quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Generate Biomedicines Inc 's ROA in the second quarter of 2026?
Generate Biomedicines Inc recorded a cumulative net loss of $-230 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -50.01%.

However, within the Healthcare sector Generate Biomedicines Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-230	-163	-101	-44	0
Return On Assets (TTM)	-50.01 %	-68.11 %	-122.42 %	-	-
GENB's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	884	626	330	0	0
Seq. Total Assets Change	41.23 %	89.51 %	-	-	-
Seq. Net Income Change	-	-	-	-	-

GENB's 5 Years Annual ROA >> Back to GENB Management Effectiveness >> Compare GENB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Generate Biomedicines Inc 's Assets	$ 884 million	GENB's Balance sheet
Generate Biomedicines Inc 's Income	$ -67 million	Quarterly GENB's Income Statement
GENB's Income by Division		See GENB's Income by Division

Annual Return On Assets	FY	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	0	0	0
Annual Return On Assets	-	-	-	-	-

GENB's 5 Years Annual ROA >> Back to GENB Management Effectiveness >> Compare GENB ROA to its Competitors

More Return On Assets Ratios
GENB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GENB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GENB's Competitors
Subscribers only: Roa for Generate Biomedicines Inc 's Suppliers
Subscribers only: Return On Assets for GENB's Customers

You may also want to know
GENB's Roi	GENB's Inventory Turnover Ratio	GENB's Growth Rates	GENB's Dividend Comparisons
	GENB's Profitability Ratios	GENB's Asset Turnover Ratio	GENB's Dividend Growth
GENB's Roe	GENB's Valuation Ratios	GENB's Financial Strength Ratios	GENB's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.